ABSTRACT A continuing search for tumor inhibitors from plant sources has yielded over two hundred extracts with reproducible growth-inhibitory activity.
INTRODUCTION
The past two decades have witnessed the synthesis of many hundreds of chemical variants of known classes of cancer chemotherapeutic agents. Synthesis of modifications of presently-known drugs does (and should) continue. However, some pessimism is evident among workers in the field, because of the relatively small improvements over the prototype drugs which have resulted from the extensive synthetic efforts to date. There exists a need for new prototypes, or templates, for the synthetic organic chemist to use in the design of potentially superior chemotherapeutic agents. As a corollary statement, there exists a need for elucidation of new biochemical mechanisms of growth regulation which may be more amenable to selective regulation. Recent studies in the isolation and structural elucidation of tumor inhibitors are yielding a fascinating array of novel types of growth-inhibitory compounds. There appears to be reason for confidence that this approach may point the way to useful templates for new synthetic approaches to cancer chemotherapy.
Studies of plant-derived tumor inhibitors are proceeding in many laboratories of wide geographic distribution. However, to limit the scope of the present discussion, the author will review only recent studies of terpenoid tumor inhibitors from his own laboratory at the University of Wisconsin.
The programme at the University of Wisconsin started modestly, in S. MORRIS KTJPCHAN and elsewhere revealed that a small but significant number of the extracts showed reproducible tumor-inhibitory activity. Encouraged by these results, the Cancer Chemotherapy National Service Center of the National Institutes of Health arranged with the U.S. Department of Agriculture to procure several thousand plant samples per year for evaluation. Shortly thereafter, the CCNSC arranged a contract with the Wisconsin Alumni Research Foundation, in Madison, to execute the initial extraction and screening studies. From that point onward, the University of Wisconsin programme concentrated on the isolation and structural elucidation of new tumor inhibitors. To date, the active principles of more than sixty active plants have been isolated in the Wisconsin programme, and the chemical studies of some of the most interesting compounds constitute the focus of this review.
ISOLATION OF TUMOR-INHIBITORY PRINCIPLES FROM

PLANTS
One aspect of the approach of our programme differs significantly from the classical, and most widely practiced, approach to the biological study of plant constituents. In the classical phytochemical approach, those compounds are studied which are most easily separated from a plant extract and most easily crystallized. In our programme, however, the fractionation and isolation studies are guided at every stage by biological assays. The systematic fractionation, guided by biological assays, has made possible the isolation of important minor constituents which would most probably have been missed in the classical approach.
Solanum dulcamara L., collected near Madison, Wisconsin, was one of the first plants found active in the Wisconsin programme. Figure 1 summarizes the fractionation procedure which led to isolation of the tumor-inhibitory principle, the steroid alkaloid glycoside fi-solamarine, whose structure is shown in Figure 2 . It is noteworthy that S. dulcamara L. has been used to treat cancers, tumors, and warts from the time of Galen (c. A.D. 180), and references to its use have appeared in the literature of many countries1.
Marak oreganus and Brandegea bigelovii Cogn.
Systematic fractionation of an exceedingly cytotoxic extract from Marah oreganus (Cucurbitaceae), from California, led to isolation of the four previously-known cucurbitacins shown in Figure 3 2 • Similar fractionation of a cytotoxic extract of Brandegea bigelovii Cogn. (Cucurbitaceae) gave three new cucurbitacins, 0, P, and Q. The structures were deduced from their formulae and spectra. Interrelation was accomplished by conversion of both cucurbitacins 0 and Q to cucurbitacin P, which was also prepared from cucurbitacin B. Conversion of cucurbitacin P to a 2,3-acetonide showed that it was the 33-hydroxy-epimer of dthydrocucurbitacin F, thus confirming its absolute configuration. The interrelationships showed that cucurbitacin 0 was 3-epi-cucurbitacin F and cucurbitacin Q its 25-acetate derivative ( Figure  4 relation with a known diterpene. Both quinone methides were converted to II, which was methylated to III. Reduction of III with lithium aluminium hydride gave the 6-alcohol IV, which was dehydrated to VI.
Catalytic hydrogenation of VI gave VII, characterized by direct comparison with a sample prepared from sugiol (VIII). Among the six diterpenoid. derivatives isolated from Taxodium distichum only the quinone methide derivatives taxodione and taxodone showed significant inhibitory activity in vivo against the Walker carcinosarcoma 256 in the rat and in vitro against cells derived from human carcinoma of the nasopharynx (KB). This fact and the known sensitivity of quinone methides to nucleophilic attack5
suggested that taxodione and taxodone might exert their biological effect by interaction with a biological nucleophile at C-7. The plausibility of the Elephantopus elatus Bertol.
A systematic study of the cytotoxic principles of Elephantopus elatus Bertol. led to the isolation of two novel tumor-inhibitory germacranolide dilactones, elephantin and elephantopin9. Although the compounds were concentrated 232 and isolated solely on the basis of in vitro cytotoxicity, elephantopin has subsequently been found to show significant inhibitory activity against the P-388 lymphocytic leukemia in the mouse and Walker carcinosarcoma 256 in the rat. (The KB cytotoxicity assay has been invaluable in many other of isolation studies as well. Significant results were frequently obtained from the bioassay of 2 to 10 mg samples of materials which could be evaluated in in vivo animal tumor systems only at the cost of 05 to 1 g samples.) A combination of degradative, spectral, and x-ray crystallographic studies resulted in elucidation of the structures of elephantin and elephantopin shown in Figure 8 . 
ADVANCES II% THE CHEMISTRY OF TERPENOID TUMOR INI{IBITORS
determined by interrelation with the x-ray defined structure of euparotin acetate11' 12 For example, eupachiorin acetate, C22H27C1O8, showed spectral characteristics indicative of the presence of an angelate ester, an a,/3-unsaturated lactone with an exocycic methylene group, an allylic acetate, and the absence of an exocyclic-epoxide-methylene grouping. Location of the chlorine atom on the C-14 methylene group was supported by the downfield shift of the signal assigned to the C-14 methylene protons (T 6.47) relative to the signal for the C-14 methylene protons (T 7.32) in the n.m.r. spectrum of euparotin acetate. Two D20-exchangeable hydroxyl proton signals were detected in contrast to one in euparotin acetate's spectrum. The tertiary nature of these hydroxyl functions was indicated by their resistance to acetylation upon treatment with acetic anhydride and pyridine. These data were consistent with the structural formula depicted in the upper right corner of Figure 10 . Chromatograpny of eupachiorin acetate upon acidwashed alumina resulted in transformation to euparotin acetate in 65 per cent yield. This interrelation proved the functional group pattern, stereochemistry, and absolute configuration of eupachiorin acetate. Incidentally, eupachiorin acetate and its companions, eupachiorin and eupachioroxin, are the first reported chlorine-containing sesquiterpenes.
Vernonia hymenolepis A. Rich
Recent studies of Vernonia hymenolepis A. Rich led to isolation and structural elucidation of two novel elemanolide dilactones, vernolepin and vernomenin. Vernolepin showed significant in vitro cytotoxicity and in vivo tumor inhibitory activity against the Walker 256 carcinosarcoma in the rat. Elemental analysis and mass spectrometry indicated a C15H1605 molecular formula for vernolepin. Chemical and spectral evidence indicated the presence of two a,-unsaturated lactone functions, a secondary alcohol, an additional double bond, and, therefore, a monocarbocyclic ring skeleton. The structure and stereochemistry for vernolepin (R = H) depicted in the upper left of Figure 11 were established by x-ray crystallographic analysis of the p-bromobenzenesuiphonate (R = SO2C6H4Br). Vernomenin showed similar chemical properties to vernolepin, and its structure was proven by (a) its conversion to the same methanol adduct as that obtained from vernolepin (lower left of Figure 11 ), and (b) a comparison of the n.m.r. spectra of the respective acetate esters (R = COCH3). In vernomenin acetate, the triplet centred at T 478 could be assigned to the proton at acetate-bearing C-6, while the multiplet centred at r 59O corresponded to the proton (spin coupled to three protons) at lactone-bearing C-8. In contrast, the spectrum of vernolepin acetate showed a multiplet at T 495, assigned to the proton at acetatebearing C-8, while the lactone proton signal appeared as a triplet centred at -596, indicative of attachment to C613. 
BIOLOGICAL ACTIVITY OF TUMOR-INHIBITORY PRINCIPLES
In an attempt to elucidate a possible function of a series of new plantderived tumor inhibitors, we enlisted the collaboration of Professor Luis Sequeira in an evaluation of the effects of these compounds on plant-growth. Several of the sesquiterpene dilactones, specffically elephantin, elephantopin, and vernolepin were found to be strong inhibitors of extension growth of wheat coleoptile sections1& Vernolepin inhibits extension growth in concentrations of 5 to 50 micrograms per ml (from 20 to 80 per cent, Figure 13) . Figure 15 , the cytotoxicity of vernolepin derivatives appears to be directly related to the presence of free conjugated a-methylene-lactone functions. Thus, selective reduction of the ethylidene double bond (vide infra) does not appear to affect the cytotoxicity. However, modification of the a-methylene-y-lactone (by transesterification to the methanol adduct or by hydrogenation) results in a 10-fold diminution in cytotoxicity. Modification of both a-methylene-lactone systems, as in hexahydrovernolepin, leads to a derivative which is essentially inactive. The synthesis of dthydrovernolepin exemplifies a new blocking sequence for the protection of the highly reactive conjugated a-methylene groups of lactones. Vernolepin was treated with an excess of n-propyl thiol at pH 92 to give a bis-thiol-adduct. Hydrogenation of the bis-thiol-adduct (with one mole-equivalent of hydrogen) followed by methyl iodide methylation and sodium bicarbonate-catalysed elimination, gave dihydrovernolepin'6. 237 We have recently studied the reactions of several conjugated a-methylenelactones with model biological nucleophiles. For instance, the rates of the reactions of vernolepin and elephantopin with cysteine at pH 74 were determined spectrophotometrically (Figure 16 ). The most reactive function in each case was the conjugated a-methylene-y-lactone, and the second order rate constants for the 'Michael-type' addition of cysteine showed the same order of reactivity towards cysteine as iodoacetate, a commonly-used sulphydryl reagent. In contrast to the reactivity of the lactones towards suiphydryl groups, their reaction with amino groups appeared to be very slow. When a solution equimolar in lysine and vernolepin at pH 74 was allowed to stand for 6 days at 25°, 75 per cent of the original lactone could be recovered. Similarly, guanine proved unreactive toward either vernolepin or elephantopin. The bis-cysteine-adducts, in accord with expectation, were essentially inactive17.
A search for the cytotoxic principle of Asciepias curassavica L. led to isolation and characterization of calotropin (Figure 17) 18.
In a parallel study, the cardenolide glycosides apocannoside and cymarin Medical School, enlisted our collaboration in a search for a selective irreversible inhibitor of transport ATPase. Ouabain and strophanthin had long been known to effect powerful and highly specific reversible inhibition of the ATPase. We undertook to modify the strophanthin molecule in the search for an irreversible inhibitor. Our first studies of the chemistry vs. the biological activity of cardenolides as cytotoxic agents, cardiotonic agents, and ATPase inhibitors revealed that only those compounds modified solely in Ring A retained the major proportion of biological activity20. We found that the aglycone, strophanthidin, retained most of the ATPase-inhibitory activity, and that the activity was not lessened by acetylation to strophanthidin 3-acetate (SA, Figure 19 ). We next prepared strophanthidin 3-bromoacetate (SBA) and strophanthidin 3-iodoacetate (SIA), and these were found to be 
ADVANCES IN THE CHEMISTRY OF TFIRPENOID TUMOR INHIBITORS
When it was found that hellebrigenin has 30 times the affinity of strophanthidin for transport ATPase, a series of hellebrigenin 3-haloacetates was synthesized. It was found that hellebrigenin 3-iodoacetate is 100 times more potent as an irreversible inhibitor of the enzyme than strophanthidin 3-bromoacetate23.
Further study of the cytotoxic principles of Bersama abyssinica Fresen. has yielded a series of new bufadienolides. We recently reported the isolation and structural elucidation of bersaldegenin 1,3,5-orthoacetate, which appears to be the first recognized naturally occurring orthoacetate (Figure 22 The programme to date has demonstrated that several new types of compounds show significant growth-inhibitory activity against standard tumor systems in the National Cancer Institute's screen. Thus, for instance, steroid lactones, sesquiterpene lactones, and diterpenoid quinone methides represent chemical types not recognized previously as growth inhibitors.
We are optimistic about the future of our approach, from several points of view. First, some of the new natural products are showing sufficient promise in the advanced predinical animal studies now in progress to become candidates for clinical trial in the near future. Secondly, we are encouraged by the fact that several of the new and remarkably cytotoxic compounds are showing usefulness as tools for studying biochemical phenomena. Finally, from a long-range point of view, we are hopeful that some of the unusual types of biologically-active compounds may serve significant roles as novel chemical templates for new synthetic approaches to cancer chemotherapy.
